Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 1, p. S5, 2020. Disponível em: https://skin.dermsquared.com/skin/article/view/809. Acesso em: 19 apr. 2025.